Symbiotec is already on a path to provide chemistry- and fermentation-based capabilities and capacity as a contract development manufacturing organicsation platform in precision fermentation, industrial biotechnology, and biologics, targeting a total addressable market of $50 billion, believes the brokerage.
Symbiotec is already on a path to provide chemistry- and fermentation-based capabilities and capacity as a contract development manufacturing organicsation platform in precision fermentation, industrial biotechnology, and biologics, targeting a total addressable market of $50 billion, believes the brokerage.
<iframe src="https://hindustansphere.com/embed/cluster/70d6e000dc15c221daddda490dd4dc2418433b53" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Symbiotec Pharmalab Gets Motilal Oswal's 'Buy' Initiation; Check Target Price"></iframe>
